> top > docs > PMC:7306567 > spans > 2624-2925 > annotations

PMC:7306567 / 2624-2925 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T5 160-164 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
53 210-235 Disease denotes graft-versus-host disease MESH:D006086
50 32-54 Disease denotes invasive aspergillosis MESH:D055744
51 112-126 Disease denotes acute leukemia MESH:D015470
52 128-130 Disease denotes AL MESH:D009101

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T23 32-54 Disease denotes invasive aspergillosis http://purl.obolibrary.org/obo/MONDO_0000240
T24 41-54 Disease denotes aspergillosis http://purl.obolibrary.org/obo/MONDO_0005657
T25 56-58 Disease denotes IA http://purl.obolibrary.org/obo/MONDO_0000240
T26 112-126 Disease denotes acute leukemia http://purl.obolibrary.org/obo/MONDO_0010643
T27 118-126 Disease denotes leukemia http://purl.obolibrary.org/obo/MONDO_0005059
T28 128-130 Disease denotes AL http://purl.obolibrary.org/obo/MONDO_0010643
T29 210-235 Disease denotes graft-versus-host disease http://purl.obolibrary.org/obo/MONDO_0013730

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T17 160-164 http://purl.obolibrary.org/obo/GO_0005623 denotes cell

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T6 56-58 Chemical denotes IA http://purl.obolibrary.org/obo/CHEBI_74062
T7 128-130 Chemical denotes AL http://purl.obolibrary.org/obo/CHEBI_73770
T8 246-256 Chemical denotes antifungal http://purl.obolibrary.org/obo/CHEBI_35718

LitCovid-PD-HP

Id Subject Object Predicate Lexical cue hp_id
T9 112-126 Phenotype denotes acute leukemia http://purl.obolibrary.org/obo/HP_0002488
T10 128-130 Phenotype denotes AL http://purl.obolibrary.org/obo/HP_0002488

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T21 0-301 Sentence denotes Patients at the highest risk of invasive aspergillosis (IA) include those undergoing intensive chemotherapy for acute leukemia (AL) or recipients of allogeneic cell transplantation (alloHCT) who develop severe graft-versus-host disease, for whom antifungal prophylaxis is currently recommended [2, 3].